Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishw Patel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Hematopathology|March 27, 2025
A rare case of multiple myeloma with double translocations: t(11;14) and t(14;16)Mina Meseha, Vishw Patel, Kirolos Sekla, et al.
Proceedings (Baylor University. Medical Center)|January 4, 2024
Protein supplementation: the double-edged swordVishw Patel, Kanishk Aggarwal, Ashish Dhawan, et al.
Clinical Genitourinary Cancer|June 25, 2026
Long-Term Survival Outcomes of Immune Checkpoint Inhibitor-based Combination Therapies in Favorable-Risk Metastatic Renal Cell Carcinoma: An Updated Pairwise and Network Meta-AnalysisSusu Zhou, Sanjay Rao Gergal Gopalkrishna Rao, Vishw Patel, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Hematopathology|March 27, 2025
A rare case of multiple myeloma with double translocations: t(11;14) and t(14;16)Mina Meseha, Vishw Patel, Kirolos Sekla, et al.
Proceedings (Baylor University. Medical Center)|January 4, 2024
Protein supplementation: the double-edged swordVishw Patel, Kanishk Aggarwal, Ashish Dhawan, et al.
Clinical Genitourinary Cancer|June 25, 2026
Long-Term Survival Outcomes of Immune Checkpoint Inhibitor-based Combination Therapies in Favorable-Risk Metastatic Renal Cell Carcinoma: An Updated Pairwise and Network Meta-AnalysisSusu Zhou, Sanjay Rao Gergal Gopalkrishna Rao, Vishw Patel, et al.
Pageof 1